Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol for Reversal of Inappropriate Left Ventricular Mass in Hypertension
NCT01605370Phase 4Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol in hypertension (HTN), sponsored by Mayo Clinic. Started Jun 2012; status: terminated.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01605370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605370.